Compare LYEL & MSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYEL | MSB |
|---|---|---|
| Founded | 2018 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | 411.8M |
| IPO Year | 2021 | 1995 |
| Metric | LYEL | MSB |
|---|---|---|
| Price | $23.86 | $31.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $30.60 | N/A |
| AVG Volume (30 Days) | ★ 76.6K | 39.5K |
| Earning Date | 05-12-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.92% |
| EPS Growth | N/A | ★ 391.29 |
| EPS | N/A | ★ 0.85 |
| Revenue | $36,000.00 | ★ $98,595,651.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16,285.34 | N/A |
| P/E Ratio | ★ N/A | $38.43 |
| Revenue Growth | N/A | ★ 331.26 |
| 52 Week Low | $0.39 | $22.55 |
| 52 Week High | $45.00 | $42.38 |
| Indicator | LYEL | MSB |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 48.16 |
| Support Level | $21.27 | $28.12 |
| Resistance Level | $27.30 | $33.00 |
| Average True Range (ATR) | 1.70 | 1.50 |
| MACD | 0.50 | 0.14 |
| Stochastic Oscillator | 80.58 | 33.25 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.